- Home
- ZVRA vs CRMD Comparison
ZVRA vs CRMD Comparison
Compare ZVRA & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZVRA | CRMD |
|---|---|---|
| Founded | 2006 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 472.9M | 509.9M |
| IPO Year | 2015 | 2009 |
Fundamental Metrics
Financial Performance| Metric | ZVRA | CRMD |
|---|---|---|
| Price | $9.80 | $7.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $23.00 | $15.20 |
| AVG Volume (30 Days) | 769.1K | ★ 1.1M |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 159.21 | ★ 780.00 |
| EPS | 1.35 | ★ 2.04 |
| Revenue | $106,470,000.00 | ★ $311,709,000.00 |
| Revenue This Year | $37.27 | $0.30 |
| Revenue Next Year | $53.42 | N/A |
| P/E Ratio | $7.20 | ★ $3.59 |
| Revenue Growth | 350.91 | ★ 617.03 |
| 52 Week Low | $6.77 | $6.13 |
| 52 Week High | $13.16 | $17.43 |
Technical Indicators
Market Signals| Indicator | ZVRA | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 55.71 | 59.93 |
| Support Level | $8.29 | $6.14 |
| Resistance Level | $10.15 | $7.44 |
| Average True Range (ATR) | 0.38 | 0.24 |
| MACD | 0.02 | 0.10 |
| Stochastic Oscillator | 78.63 | 81.08 |
Price Performance
Historical ComparisonAbout ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.